- Viatris
- Overview
- Last Modified:
- January 6, 2025
- Company type:
- Public
- Industry:
- Healthcare
- Verified:
- No
- No of Employees:
- 10 001 - 50 000
- Stock Code:
- VTRS
- Download
- Signed Health Status Declaration Form
- Turnover $50m + ?:
- Yes
- Headquarters:
- Canonsburg, Pennsylvania, United States
- Public Interest Score:
- 750+
- Viatris
- General Information
Description
Viatris is a global healthcare company which we believe is uniquely positioned to bridge the traditional divide between generics and brands,
combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every
stage of life, Viatris provides access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and
touching all of life’s moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of
medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some
of the world’s most enduring health challenges, access takes on deep meaning at Viatris
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Scott Smith:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
JoEllen Dillon:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Don Cornwell:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Elisha Finney:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Leo Groothuis:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
James Kilts:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Harry Korman:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Rajiv Malik:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Richard Mark:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Mark Parrish:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Rogerio Coelho:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Subsribe/ Login to view details on company risk rating
5 Benchmark > 4 Excellent > 3Â Good > 2 Caution > 1 Risk
- Company Information
- Company System Number:
- 15402
- Founded Year:
- 2020
- Registration Number:
- 83-4364296
- Country:
- United States of America
- Stock Exchanges:
-
- NASDAQ Stock Exchange
- Financial year end:
- December
- No. of Countries operations:
- 37
- Company Status:
- In Business
- Industry Sub Category:
- Medicines, Medical devices, and Vaccines.
- Date listed on Stock Exchange:
- 12/11/2020
- Contact Information
- Business operation:
- We are a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both, to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale.
- Primary office:
- Canonsburg, Pennsylvania, United States
- Additional Information
- Listed?:
- Yes
- Company secretary:
- Reporting currency:
- USD
- ISIN number (12 digit):
NDAQ
US92556V1061- Authorised shares:
- 300 000 0000
- Issued shares:
- 1221 994 491
- No of shareholders:
- 1001 and more shareholders
- No of shareholders holding 20%:
- 0 shareholders
- Number of shares traded
- Per Year:
- Per Quarter:
- Per Month:
Credit Rating
| Name | Logo | Country | Headquarters | Rating |
|---|---|---|---|---|
| Moody's | United States of America | New York | Aaa | |
| S&P | United States of America | New York | AA+ |
Countries Operations/ Offices
Company Directors
Melina
Non ExecutiveScott
Non ExecutiveJoEllen
Non ExecutiveDon
Non ExecutiveElisha
Non ExecutiveLeo
Non ExecutiveJames
Non ExecutiveHarry
Non ExecutiveRajiv
ExecutiveRichard
Non ExecutiveMark
Non Executive
Directors Tenure
Director Experience
Company Auditors
Company Committees
|
Committee
|
Abbreviation
|
|---|---|
|
Supervisory Board
|
SB
|
|
Board
|
BD
|
|
Risk & Compliance
|
RC
|
|
Audit
|
AU
|
|
Remuneration
|
RE
|
|
Capital investment
|
CI
|
|
Industry Specific
|
IS
|
|
Nominations & Governance
|
NG
|
|
Health, Safety & Environment
|
HS
|
|
Social & Ethics
|
SE
|
|
Technology
|
TE
|
|
Executive
|
EX
|
|
Other
|
OT
|
